M
Molecubes
Biotech & Life Sciences · Ghent, Belgium · Founded 2015
Preclinical in-vivo imaging systems MoreLess
Molecubes, founded in 2015 as a spin-off from Ghent University-iMinds in Belgium, develops and manufactures modular benchtop preclinical imaging systems. The company was established by Professor Dr. Roel Van Holen, along with co-founders Pieter Mollet, Bert Vandeghinste, and Ewout Vansteenkiste, based on research to make complex molecular imaging technology more accessible. In January 2016, the company secured €1.9 million in seed funding to launch its initial products.
The company's core business is providing compact and user-friendly in-vivo imaging solutions for life science research. Its primary clients include academic and government research laboratories, pharmaceutical and biotechnology companies, and contract research organizations (CROs). The business model centers on the sale of its hardware, the 'CUBES', which are designed for high-performance imaging while maintaining a small footprint suitable for any lab bench. In November 2021, Molecubes was acquired by Bruker Corporation, a move intended to strengthen Bruker's preclinical imaging portfolio and expand the global reach of the CUBES technology. Molecubes continues to operate as an agile team within Bruker's BioSpin Preclinical Imaging division.
Molecubes offers three main products, each a separate benchtop imager that can be used as a standalone unit or in modular combination: the β-CUBE (a high-sensitivity micro-PET scanner), the γ-CUBE (a high-resolution micro-SPECT scanner), and the X-CUBE (a high-throughput, low-dose micro-CT scanner). These systems are designed for whole-body imaging of mice and rats, supporting research in fields like oncology, neurology, and cardiology. A key feature is their modularity, allowing researchers to perform PET/CT, SPECT/CT, or PET/SPECT/CT studies and enabling multiple users to work simultaneously. The systems are supported by intuitive, wireless software that simplifies workflows and makes advanced 3D imaging accessible to a broader range of researchers.
Keywords: preclinical imaging, molecular imaging, PET scanners, SPECT scanners, CT scanners, benchtop imagers, life science research, drug discovery, small animal imaging, modular imaging systems
Company overview
Molecubes company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2015
- Headquarters
- Ghent, Belgium
- Employees
- 16
- Open positions
- None listed
- Dealroom signal
- 66.6
Valuation & funding
Molecubes funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Nov 2021 | $0 | — | Bruker | ↗ |
| SEED✓Equity / VC | Jan 2016 | $2.2M | $8.8M | Undisclosed | ↗ |
| SPINOUT✓Other financing | Jan 2015 | $0 | — | imec · Ghent University | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | EBITDA | Margin | Profit | Margin |
|---|---|---|---|---|
| 2026 | $3M | — | $3.1M | — |
| 2025 | $3M | — | $3.1M | — |
| 2024 | $3M | — | $3.1M | — |
| 2023 | $3M | — | ||
| 2022 | $3M | — | ||
| 2021 | $1.2M | — | ||
| 2020 | $1.7M | — |
Growth signals
Molecubes website traffic
Latest recorded traffic for Molecubes is 2.4K monthly website visits, up 3900% over the last three months. Molecubes's team declined 11.1% over the past year.
Comparisons
Molecubes compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Molecubes's talent
Source: Dealroom Talent Intelligence.
Investors
7 investors on Molecubes's cap table
Sourced from Dealroom's funding and investor records.






Global footprint
Where Molecubes has talent and traffic
team presence
In the news
Latest news about Molecubes
Recent press, funding announcements, and product moves mentioning Molecubes — open to read from the original sources.
Market sentiment
What the market is saying about Molecubes
An AI-synthesized read of the highest-engagement posts about Molecubes on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Molecubes’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







